drugset / Trial / NCT01390051

Can Low Molecular Weight Heparin During Pregnancy With Intrauterine Growth Restriction Increase Birth Weight?

NCT01390051

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of the study is to investigate if treatment with an anticoagulant drug increases birth weight in pregnancies complicated by fetal growth restriction.

Timeline

Start
2011-07
Primary completion
2016-07
Completion
2016-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tinzaparin Other / unclassified 4500 iu Subcutaneous